One of the Bank of England’s policymakers stated that with interest rates at a low level of nearly zero, a no-deal Brexit could lead to a prolonged result.
The new guidelines now incorporate guidelines for pharmaceutical precursors under a single framework, whereas said guidelines were previously separated from guidelines for pharmaceutical and/or medicinal ingredients.